Amy O'Sullivan

SVP and Chief Scientific Officer at Ontada

Amy O'Sullivan has over 25 years of experience in health economics and outcomes research. Currently, they are working at Ontada as the SVP and Chief Scientific Officer. Previously, they worked at ISPOR as the Past President of the Boston Regional Chapter and held the position of President and President-Elect. Amy was also a Chief Member at Chief. Prior to that, they worked at Alkermes as Vice President of Health Economics and Outcomes Research and Managed Markets Liaisons, Vertex Pharmaceuticals as Senior Director of Global Health Economics & Outcomes Research and as an Adjunct Assistant Professor at Boston University School of Public Health. Amy has also held senior positions at OptumInsight Life Sciences and Innovus Research, Inc. Their career began as a Research Assistant at Policy Analysis Inc.

Amy O'Sullivan completed their PhD in Health Economics from Johns Hopkins School of Public Health in 2002. No information is available about their education before attending Johns Hopkins, but it is known that they did not receive any degree from Boston College.

Links

Previous companies

Vertex Pharmaceuticals logo
Alkermes logo

Timeline

  • SVP and Chief Scientific Officer

    March, 2022 - present